TABLE 1 BRAND REVENUE ANALYSIS FOR VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET
TABLE 2 GLOBAL VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2031 (USD MILLION)
TABLE 3 GLOBAL NON-STEROIDAL ANTI- INFLAMMATORY DTUGS (NSAIDS) IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 4 GLOBAL NON-STEROIDAL ANTI- INFLAMMATORY DRUGS(NSAIDS) IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 5 GLOBAL ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 6 GLOBAL ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 7 GLOBAL ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 8 GLOBAL VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 9 GLOBAL VACCINES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2031 (USD MILLION)
TABLE 10 GLOBAL COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 11 GLOBAL WHOLE VIRUS VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 12 GLOBAL COMPONENT VIRAL VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 13 GLOBAL COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY VARIANT, 2022-2031 (USD MILLION)
TABLE 14 GLOBAL INFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 15 GLOBAL MONOCLONAL ANTIIBODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 16 GLOBAL MONOCLONAL ANTIBODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 17 GLOBAL MONOCLONAL ANTIBODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 18 GLOBAL OTHERS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 19 GLOBAL VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 20 GLOBAL PRESCRIPTION BASED IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 21 GLOBAL OTC IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 22 GLOBAL VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 23 GLOBAL NASAL IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 24 GLOBAL ORAL IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 25 GLOBAL ORAL IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 26 GLOBAL INJECTABLE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 27 GLOBAL INJECTABLE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 28 GLOBAL VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 29 GLOBAL COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 30 GLOBAL RHINOVIRUS (COMMON COLD) IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 31 GLOBAL RESPIRATORY SYNCYTIAL VIRUS (RSV) IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 32 GLOBAL INFLUENZA (FLU) IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 33 GLOBAL PARAINFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 34 GLOBAL PARAINFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 35 GLOBAL ADENOVIRUSES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 36 GLOBAL ENTEROVIRUS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 37 GLOBAL ENTEROVIRUS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 38 GLOBAL OTHERS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 39 GLOBAL VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY INFECTION TYPE, 2022-2031 (USD MILLION)
TABLE 40 GLOBAL LOWER RESPIRATORY INFECTIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 41 GLOBAL UPPER RESPIRATORY INFECTIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 42 GLOBAL VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY POPULATION, 2022-2031 (USD MILLION)
TABLE 43 GLOBAL GERIATRIC IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 44 GLOBAL PEDIATRIC IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 45 GLOBAL ADULTS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 46 GLOBAL VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
TABLE 47 GLOBAL MALE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 48 GLOBAL FEMALE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 49 GLOBAL VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 50 GLOBAL HOSPITALS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 51 GLOBAL HOSPITALS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 52 GLOBAL AMBULATORY SURGICAL CENTERS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 53 GLOBAL CLINICS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 54 GLOBAL HOME CARE SETTINGS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 55 GLOBAL RESEARCH INSTITUTES AND ACADEMIC CENTERS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 56 GLOBAL VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 57 GLOBAL DIRECT TENDER IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 58 GLOBAL RETAIL SALES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 59 GLOBAL RETAIL SALES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 60 GLOBAL OTHERS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 61 GLOBAL VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 62 NORTH AMERICA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 63 NORTH AMERICA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2031 (USD MILLION)
TABLE 64 NORTH AMERICA NON-STEROIDAL ANTI-INFLAMMATORY (NSAIDS) IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 65 NORTH AMERICA ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 66 NORTH AMERICA ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 67 NORTH AMERICA VACCINES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE , 2022-2031 (USD MILLION)
TABLE 68 NORTH AMERICA COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 69 NORTH AMERICA WHOLE VIRUS VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 70 NORTH AMERICA COMPONENT VIRAL VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 71 NORTH AMERICA COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY VARIANT , 2022-2031 (USD MILLION)
TABLE 72 NORTH AMERICA INFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 73 NORTH AMERICA MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 74 NORTH AMERICA MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 75 NORTH AMERICA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 76 NORTH AMERICA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 77 NORTH AMERICA ORAL IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 78 NORTH AMERICA INJECTABLES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 79 NORTH AMERICA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 80 NORTH AMERICA PARAINFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 81 NORTH AMERICA ENTEROVIRUS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 82 NORTH AMERICA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY INFECTION TYPE, 2022-2031 (USD MILLION)
TABLE 83 NORTH AMERICA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY POPULATION, 2022-2031 (USD MILLION)
TABLE 84 NORTH AMERICA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
TABLE 85 NORTH AMERICA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 86 NORTH AMERICA HOSPITALS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 87 NORTH AMERICA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 88 NORTH AMERICA RETAIL SALES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 89 U.S. VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2031 (USD MILLION)
TABLE 90 U.S. NON-STEROIDAL ANTI-INFLAMMATORY (NSAIDS) IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 91 U.S. ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 92 U.S. ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 93 U.S. VACCINES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE , 2022-2031 (USD MILLION)
TABLE 94 U.S. COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 95 U.S. WHOLE VIRUS VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 96 U.S. COMPONENT VIRAL VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 97 U.S. COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY VARIANT , 2022-2031 (USD MILLION)
TABLE 98 U.S. INFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 99 U.S. MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 100 U.S. MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 101 U.S. VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 102 U.S. VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 103 U.S. ORAL IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 104 U.S. INJECTABLES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 105 U.S. VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 106 U.S. PARAINFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 107 U.S. ENTEROVIRUS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 108 U.S. VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY INFECTION TYPE, 2022-2031 (USD MILLION)
TABLE 109 U.S. VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY POPULATION, 2022-2031 (USD MILLION)
TABLE 110 U.S. VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
TABLE 111 U.S. VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 112 U.S. HOSPITALS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 113 U.S. VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 114 U.S. RETAIL SALES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 115 CANADA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2031 (USD MILLION)
TABLE 116 CANADA NON-STEROIDAL ANTI-INFLAMMATORY (NSAIDS) IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 117 CANADA ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 118 CANADA ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 119 CANADA VACCINES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE , 2022-2031 (USD MILLION)
TABLE 120 CANADA COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 121 CANADA WHOLE VIRUS VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 122 CANADA COMPONENT VIRAL VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 123 CANADA COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY VARIANT , 2022-2031 (USD MILLION)
TABLE 124 CANADA INFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 125 CANADA MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 126 CANADA MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 127 CANADA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 128 CANADA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 129 CANADA ORAL IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 130 CANADA INJECTABLES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 131 CANADA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 132 CANADA PARAINFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 133 CANADA ENTEROVIRUS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 134 CANADA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY INFECTION TYPE, 2022-2031 (USD MILLION)
TABLE 135 CANADA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY POPULATION, 2022-2031 (USD MILLION)
TABLE 136 CANADA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
TABLE 137 CANADA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 138 CANADA HOSPITALS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 139 CANADA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 140 CANADA RETAIL SALES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 141 MEXICO VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2031 (USD MILLION)
TABLE 142 MEXICO NON-STEROIDAL ANTI-INFLAMMATORY (NSAIDS) IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 143 MEXICO ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 144 MEXICO ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 145 MEXICO VACCINES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE , 2022-2031 (USD MILLION)
TABLE 146 MEXICO COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 147 MEXICO WHOLE VIRUS VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 148 MEXICO COMPONENT VIRAL VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 149 MEXICO COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY VARIANT , 2022-2031 (USD MILLION)
TABLE 150 MEXICO INFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 151 MEXICO MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 152 MEXICO MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 153 MEXICO VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 154 MEXICO VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 155 MEXICO ORAL IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 156 MEXICO INJECTABLES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 157 MEXICO VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 158 MEXICO PARAINFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 159 MEXICO ENTEROVIRUS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 160 MEXICO VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY INFECTION TYPE, 2022-2031 (USD MILLION)
TABLE 161 MEXICO VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY POPULATION, 2022-2031 (USD MILLION)
TABLE 162 MEXICO VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
TABLE 163 MEXICO VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 164 MEXICO HOSPITALS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 165 MEXICO VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 166 MEXICO RETAIL SALES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 167 EUROPE VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 168 EUROPE VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2031 (USD MILLION)
TABLE 169 EUROPE NON-STEROIDAL ANTI-INFLAMMATORY (NSAIDS) IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 170 EUROPE ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 171 EUROPE ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 172 EUROPE VACCINES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE , 2022-2031 (USD MILLION)
TABLE 173 EUROPE COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 174 EUROPE WHOLE VIRUS VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 175 EUROPE COMPONENT VIRAL VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 176 EUROPE COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY VARIANT , 2022-2031 (USD MILLION)
TABLE 177 EUROPE INFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 178 EUROPE MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 179 EUROPE MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 180 EUROPE VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 181 EUROPE VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 182 EUROPE ORAL IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 183 EUROPE INJECTABLES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 184 EUROPE VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 185 EUROPE PARAINFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 186 EUROPE ENTEROVIRUS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 187 EUROPE VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY INFECTION TYPE, 2022-2031 (USD MILLION)
TABLE 188 EUROPE VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY POPULATION, 2022-2031 (USD MILLION)
TABLE 189 EUROPE VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
TABLE 190 EUROPE VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 191 EUROPE HOSPITALS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 192 EUROPE VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 193 EUROPE RETAIL SALES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 194 GERMANY VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2031 (USD MILLION)
TABLE 195 GERMANY NON-STEROIDAL ANTI-INFLAMMATORY (NSAIDS) IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 196 GERMANY ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 197 GERMANY ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 198 GERMANY VACCINES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE , 2022-2031 (USD MILLION)
TABLE 199 GERMANY COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 200 GERMANY WHOLE VIRUS VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 201 GERMANY COMPONENT VIRAL VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 202 GERMANY COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY VARIANT , 2022-2031 (USD MILLION)
TABLE 203 GERMANY INFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 204 GERMANY MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 205 GERMANY MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 206 GERMANY VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 207 GERMANY VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 208 GERMANY ORAL IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 209 GERMANY INJECTABLES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 210 GERMANY VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 211 GERMANY PARAINFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 212 GERMANY ENTEROVIRUS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 213 GERMANY VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY INFECTION TYPE, 2022-2031 (USD MILLION)
TABLE 214 GERMANY VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY POPULATION, 2022-2031 (USD MILLION)
TABLE 215 GERMANY VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
TABLE 216 GERMANY VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 217 GERMANY HOSPITALS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 218 GERMANY VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 219 GERMANY RETAIL SALES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 220 FRANCE VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2031 (USD MILLION)
TABLE 221 FRANCE NON-STEROIDAL ANTI-INFLAMMATORY (NSAIDS) IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 222 FRANCE ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 223 FRANCE ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 224 FRANCE VACCINES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE , 2022-2031 (USD MILLION)
TABLE 225 FRANCE COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 226 FRANCE WHOLE VIRUS VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 227 FRANCE COMPONENT VIRAL VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 228 FRANCE COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY VARIANT , 2022-2031 (USD MILLION)
TABLE 229 FRANCE INFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 230 FRANCE MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 231 FRANCE MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 232 FRANCE VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 233 FRANCE VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 234 FRANCE ORAL IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 235 FRANCE INJECTABLES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 236 FRANCE VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 237 FRANCE PARAINFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 238 FRANCE ENTEROVIRUS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 239 FRANCE VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY INFECTION TYPE, 2022-2031 (USD MILLION)
TABLE 240 FRANCE VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY POPULATION, 2022-2031 (USD MILLION)
TABLE 241 FRANCE VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
TABLE 242 FRANCE VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 243 FRANCE HOSPITALS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 244 FRANCE VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 245 FRANCE RETAIL SALES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 246 U.K. VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2031 (USD MILLION)
TABLE 247 U.K. NON-STEROIDAL ANTI-INFLAMMATORY (NSAIDS) IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 248 U.K. ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 249 U.K. ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 250 U.K. VACCINES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE , 2022-2031 (USD MILLION)
TABLE 251 U.K. COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 252 U.K. WHOLE VIRUS VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 253 U.K. COMPONENT VIRAL VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 254 U.K. COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY VARIANT , 2022-2031 (USD MILLION)
TABLE 255 U.K. INFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 256 U.K. MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 257 U.K. MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 258 U.K. VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 259 U.K. VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 260 U.K. ORAL IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 261 U.K. INJECTABLES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 262 U.K. VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 263 U.K. PARAINFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 264 U.K. ENTEROVIRUS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 265 U.K. VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY INFECTION TYPE, 2022-2031 (USD MILLION)
TABLE 266 U.K. VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY POPULATION, 2022-2031 (USD MILLION)
TABLE 267 U.K. VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
TABLE 268 U.K. VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 269 U.K. HOSPITALS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 270 U.K. VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 271 U.K. RETAIL SALES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 272 ITALY VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2031 (USD MILLION)
TABLE 273 ITALY NON-STEROIDAL ANTI-INFLAMMATORY (NSAIDS) IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 274 ITALY ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 275 ITALY ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 276 ITALY VACCINES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE , 2022-2031 (USD MILLION)
TABLE 277 ITALY COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 278 ITALY WHOLE VIRUS VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 279 ITALY COMPONENT VIRAL VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 280 ITALY COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY VARIANT , 2022-2031 (USD MILLION)
TABLE 281 ITALY INFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 282 ITALY MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 283 ITALY MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 284 ITALY VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 285 ITALY VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 286 ITALY ORAL IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 287 ITALY INJECTABLES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 288 ITALY VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 289 ITALY PARAINFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 290 ITALY ENTEROVIRUS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 291 ITALY VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY INFECTION TYPE, 2022-2031 (USD MILLION)
TABLE 292 ITALY VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY POPULATION, 2022-2031 (USD MILLION)
TABLE 293 ITALY VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
TABLE 294 ITALY VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 295 ITALY HOSPITALS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 296 ITALY VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 297 ITALY RETAIL SALES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 298 RUSSIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2031 (USD MILLION)
TABLE 299 RUSSIA NON-STEROIDAL ANTI-INFLAMMATORY (NSAIDS) IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 300 RUSSIA ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 301 RUSSIA ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 302 RUSSIA VACCINES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE , 2022-2031 (USD MILLION)
TABLE 303 RUSSIA COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 304 RUSSIA WHOLE VIRUS VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 305 RUSSIA COMPONENT VIRAL VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 306 RUSSIA COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY VARIANT , 2022-2031 (USD MILLION)
TABLE 307 RUSSIA INFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 308 RUSSIA MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 309 RUSSIA MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 310 RUSSIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 311 RUSSIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 312 RUSSIA ORAL IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 313 RUSSIA INJECTABLES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 314 RUSSIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 315 RUSSIA PARAINFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 316 RUSSIA ENTEROVIRUS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 317 RUSSIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY INFECTION TYPE, 2022-2031 (USD MILLION)
TABLE 318 RUSSIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY POPULATION, 2022-2031 (USD MILLION)
TABLE 319 RUSSIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
TABLE 320 RUSSIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 321 RUSSIA HOSPITALS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 322 RUSSIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 323 RUSSIA RETAIL SALES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 324 SPAIN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2031 (USD MILLION)
TABLE 325 SPAIN NON-STEROIDAL ANTI-INFLAMMATORY (NSAIDS) IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 326 SPAIN ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 327 SPAIN ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 328 SPAIN VACCINES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE , 2022-2031 (USD MILLION)
TABLE 329 SPAIN COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 330 SPAIN WHOLE VIRUS VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 331 SPAIN COMPONENT VIRAL VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 332 SPAIN COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY VARIANT , 2022-2031 (USD MILLION)
TABLE 333 SPAIN INFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 334 SPAIN MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 335 SPAIN MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 336 SPAIN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 337 SPAIN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 338 SPAIN ORAL IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 339 SPAIN INJECTABLES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 340 SPAIN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 341 SPAIN PARAINFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 342 SPAIN ENTEROVIRUS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 343 SPAIN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY INFECTION TYPE, 2022-2031 (USD MILLION)
TABLE 344 SPAIN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY POPULATION, 2022-2031 (USD MILLION)
TABLE 345 SPAIN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
TABLE 346 SPAIN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 347 SPAIN HOSPITALS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 348 SPAIN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 349 SPAIN RETAIL SALES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 350 TURKEY VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2031 (USD MILLION)
TABLE 351 TURKEY NON-STEROIDAL ANTI-INFLAMMATORY (NSAIDS) IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 352 TURKEY ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 353 TURKEY ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 354 TURKEY VACCINES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE , 2022-2031 (USD MILLION)
TABLE 355 TURKEY COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 356 TURKEY WHOLE VIRUS VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 357 TURKEY COMPONENT VIRAL VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 358 TURKEY COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY VARIANT , 2022-2031 (USD MILLION)
TABLE 359 TURKEY INFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 360 TURKEY MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 361 TURKEY MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 362 TURKEY VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 363 TURKEY VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 364 TURKEY ORAL IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 365 TURKEY INJECTABLES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 366 TURKEY VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 367 TURKEY PARAINFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 368 TURKEY ENTEROVIRUS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 369 TURKEY VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY INFECTION TYPE, 2022-2031 (USD MILLION)
TABLE 370 TURKEY VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY POPULATION, 2022-2031 (USD MILLION)
TABLE 371 TURKEY VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
TABLE 372 TURKEY VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 373 TURKEY HOSPITALS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 374 TURKEY VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 375 TURKEY RETAIL SALES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 376 NETHERLANDS VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2031 (USD MILLION)
TABLE 377 NETHERLANDS NON-STEROIDAL ANTI-INFLAMMATORY (NSAIDS) IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 378 NETHERLANDS ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 379 NETHERLANDS ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 380 NETHERLANDS VACCINES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE , 2022-2031 (USD MILLION)
TABLE 381 NETHERLANDS COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 382 NETHERLANDS WHOLE VIRUS VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 383 NETHERLANDS COMPONENT VIRAL VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 384 NETHERLANDS COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY VARIANT , 2022-2031 (USD MILLION)
TABLE 385 NETHERLANDS INFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 386 NETHERLANDS MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 387 NETHERLANDS MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 388 NETHERLANDS VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 389 NETHERLANDS VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 390 NETHERLANDS ORAL IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 391 NETHERLANDS INJECTABLES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 392 NETHERLANDS VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 393 NETHERLANDS PARAINFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 394 NETHERLANDS ENTEROVIRUS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 395 NETHERLANDS VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY INFECTION TYPE, 2022-2031 (USD MILLION)
TABLE 396 NETHERLANDS VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY POPULATION, 2022-2031 (USD MILLION)
TABLE 397 NETHERLANDS VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
TABLE 398 NETHERLANDS VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 399 NETHERLANDS HOSPITALS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 400 NETHERLANDS VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 401 NETHERLANDS RETAIL SALES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 402 SWITZERLAND VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2031 (USD MILLION)
TABLE 403 SWITZERLAND NON-STEROIDAL ANTI-INFLAMMATORY (NSAIDS) IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 404 SWITZERLAND ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 405 SWITZERLAND ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 406 SWITZERLAND VACCINES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE , 2022-2031 (USD MILLION)
TABLE 407 SWITZERLAND COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 408 SWITZERLAND WHOLE VIRUS VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 409 SWITZERLAND COMPONENT VIRAL VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 410 SWITZERLAND COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY VARIANT , 2022-2031 (USD MILLION)
TABLE 411 SWITZERLAND INFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 412 SWITZERLAND MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 413 SWITZERLAND MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 414 SWITZERLAND VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 415 SWITZERLAND VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 416 SWITZERLAND ORAL IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 417 SWITZERLAND INJECTABLES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 418 SWITZERLAND VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 419 SWITZERLAND PARAINFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 420 SWITZERLAND ENTEROVIRUS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 421 SWITZERLAND VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY INFECTION TYPE, 2022-2031 (USD MILLION)
TABLE 422 SWITZERLAND VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY POPULATION, 2022-2031 (USD MILLION)
TABLE 423 SWITZERLAND VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
TABLE 424 SWITZERLAND VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 425 SWITZERLAND HOSPITALS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 426 SWITZERLAND VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 427 SWITZERLAND RETAIL SALES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 428 BELGIUM VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2031 (USD MILLION)
TABLE 429 BELGIUM NON-STEROIDAL ANTI-INFLAMMATORY (NSAIDS) IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 430 BELGIUM ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 431 BELGIUM ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 432 BELGIUM VACCINES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE , 2022-2031 (USD MILLION)
TABLE 433 BELGIUM COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 434 BELGIUM WHOLE VIRUS VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 435 BELGIUM COMPONENT VIRAL VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 436 BELGIUM COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY VARIANT , 2022-2031 (USD MILLION)
TABLE 437 BELGIUM INFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 438 BELGIUM MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 439 BELGIUM MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 440 BELGIUM VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 441 BELGIUM VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 442 BELGIUM ORAL IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 443 BELGIUM INJECTABLES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 444 BELGIUM VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 445 BELGIUM PARAINFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 446 BELGIUM ENTEROVIRUS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 447 BELGIUM VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY INFECTION TYPE, 2022-2031 (USD MILLION)
TABLE 448 BELGIUM VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY POPULATION, 2022-2031 (USD MILLION)
TABLE 449 BELGIUM VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
TABLE 450 BELGIUM VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 451 BELGIUM HOSPITALS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 452 BELGIUM VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 453 BELGIUM RETAIL SALES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 454 REST OF EUROPE VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2031 (USD MILLION)
TABLE 455 ASIA-PACIFIC VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 456 ASIA-PACIFIC VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2031 (USD MILLION)
TABLE 457 ASIA-PACIFIC NON-STEROIDAL ANTI-INFLAMMATORY (NSAIDS) IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 458 ASIA-PACIFIC ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 459 ASIA-PACIFIC ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 460 ASIA-PACIFIC VACCINES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE , 2022-2031 (USD MILLION)
TABLE 461 ASIA-PACIFIC COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 462 ASIA-PACIFIC WHOLE VIRUS VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 463 ASIA-PACIFIC COMPONENT VIRAL VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 464 ASIA-PACIFIC COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY VARIANT , 2022-2031 (USD MILLION)
TABLE 465 ASIA-PACIFIC INFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 466 ASIA-PACIFIC MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 467 ASIA-PACIFIC MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 468 ASIA-PACIFIC VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 469 ASIA-PACIFIC VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 470 ASIA-PACIFIC ORAL IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 471 ASIA-PACIFIC INJECTABLES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 472 ASIA-PACIFIC VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 473 ASIA-PACIFIC PARAINFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 474 ASIA-PACIFIC ENTEROVIRUS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 475 ASIA-PACIFIC VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY INFECTION TYPE, 2022-2031 (USD MILLION)
TABLE 476 ASIA-PACIFIC VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY POPULATION, 2022-2031 (USD MILLION)
TABLE 477 ASIA-PACIFIC VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
TABLE 478 ASIA-PACIFIC VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 479 ASIA-PACIFIC HOSPITALS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 480 ASIA-PACIFIC VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 481 ASIA-PACIFIC RETAIL SALES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 482 CHINA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2031 (USD MILLION)
TABLE 483 CHINA NON-STEROIDAL ANTI-INFLAMMATORY (NSAIDS) IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 484 CHINA ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 485 CHINA ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 486 CHINA VACCINES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE , 2022-2031 (USD MILLION)
TABLE 487 CHINA COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 488 CHINA WHOLE VIRUS VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 489 CHINA COMPONENT VIRAL VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 490 CHINA COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY VARIANT , 2022-2031 (USD MILLION)
TABLE 491 CHINA INFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 492 CHINA MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 493 CHINA MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 494 CHINA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 495 CHINA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 496 CHINA ORAL IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 497 CHINA INJECTABLES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 498 CHINA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 499 CHINA PARAINFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 500 CHINA ENTEROVIRUS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 501 CHINA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY INFECTION TYPE, 2022-2031 (USD MILLION)
TABLE 502 CHINA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY POPULATION, 2022-2031 (USD MILLION)
TABLE 503 CHINA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
TABLE 504 CHINA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 505 CHINA HOSPITALS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 506 CHINA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 507 CHINA RETAIL SALES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 508 JAPAN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2031 (USD MILLION)
TABLE 509 JAPAN NON-STEROIDAL ANTI-INFLAMMATORY (NSAIDS) IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 510 JAPAN ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 511 JAPAN ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 512 JAPAN VACCINES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE , 2022-2031 (USD MILLION)
TABLE 513 JAPAN COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 514 JAPAN WHOLE VIRUS VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 515 JAPAN COMPONENT VIRAL VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 516 JAPAN COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY VARIANT , 2022-2031 (USD MILLION)
TABLE 517 JAPAN INFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 518 JAPAN MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 519 JAPAN MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 520 JAPAN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 521 JAPAN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 522 JAPAN ORAL IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 523 JAPAN INJECTABLES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 524 JAPAN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 525 JAPAN PARAINFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 526 JAPAN ENTEROVIRUS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 527 JAPAN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY INFECTION TYPE, 2022-2031 (USD MILLION)
TABLE 528 JAPAN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY POPULATION, 2022-2031 (USD MILLION)
TABLE 529 JAPAN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
TABLE 530 JAPAN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 531 JAPAN HOSPITALS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 532 JAPAN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 533 JAPAN RETAIL SALES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 534 INDIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2031 (USD MILLION)
TABLE 535 INDIA NON-STEROIDAL ANTI-INFLAMMATORY (NSAIDS) IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 536 INDIA ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 537 INDIA ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 538 INDIA VACCINES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE , 2022-2031 (USD MILLION)
TABLE 539 INDIA COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 540 INDIA WHOLE VIRUS VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 541 INDIA COMPONENT VIRAL VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 542 INDIA COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY VARIANT , 2022-2031 (USD MILLION)
TABLE 543 INDIA INFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 544 INDIA MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 545 INDIA MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 546 INDIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 547 INDIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 548 INDIA ORAL IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 549 INDIA INJECTABLES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 550 INDIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 551 INDIA PARAINFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 552 INDIA ENTEROVIRUS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 553 INDIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY INFECTION TYPE, 2022-2031 (USD MILLION)
TABLE 554 INDIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY POPULATION, 2022-2031 (USD MILLION)
TABLE 555 INDIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
TABLE 556 INDIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 557 INDIA HOSPITALS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 558 INDIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 559 INDIA RETAIL SALES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 560 SOUTH KOREA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2031 (USD MILLION)
TABLE 561 SOUTH KOREA NON-STEROIDAL ANTI-INFLAMMATORY (NSAIDS) IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 562 SOUTH KOREA ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 563 SOUTH KOREA ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 564 SOUTH KOREA VACCINES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE , 2022-2031 (USD MILLION)
TABLE 565 SOUTH KOREA COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 566 SOUTH KOREA WHOLE VIRUS VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 567 SOUTH KOREA COMPONENT VIRAL VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 568 SOUTH KOREA COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY VARIANT , 2022-2031 (USD MILLION)
TABLE 569 SOUTH KOREA INFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 570 SOUTH KOREA MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 571 SOUTH KOREA MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 572 SOUTH KOREA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 573 SOUTH KOREA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 574 SOUTH KOREA ORAL IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 575 SOUTH KOREA INJECTABLES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 576 SOUTH KOREA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 577 SOUTH KOREA PARAINFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 578 SOUTH KOREA ENTEROVIRUS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 579 SOUTH KOREA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY INFECTION TYPE, 2022-2031 (USD MILLION)
TABLE 580 SOUTH KOREA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY POPULATION, 2022-2031 (USD MILLION)
TABLE 581 SOUTH KOREA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
TABLE 582 SOUTH KOREA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 583 SOUTH KOREA HOSPITALS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 584 SOUTH KOREA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 585 SOUTH KOREA RETAIL SALES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 586 AUSTRALIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2031 (USD MILLION)
TABLE 587 AUSTRALIA NON-STEROIDAL ANTI-INFLAMMATORY (NSAIDS) IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 588 AUSTRALIA ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 589 AUSTRALIA ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 590 AUSTRALIA VACCINES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE , 2022-2031 (USD MILLION)
TABLE 591 AUSTRALIA COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 592 AUSTRALIA WHOLE VIRUS VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 593 AUSTRALIA COMPONENT VIRAL VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 594 AUSTRALIA COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY VARIANT , 2022-2031 (USD MILLION)
TABLE 595 AUSTRALIA INFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 596 AUSTRALIA MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 597 AUSTRALIA MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 598 AUSTRALIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 599 AUSTRALIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 600 AUSTRALIA ORAL IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 601 AUSTRALIA INJECTABLES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 602 AUSTRALIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 603 AUSTRALIA PARAINFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 604 AUSTRALIA ENTEROVIRUS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 605 AUSTRALIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY INFECTION TYPE, 2022-2031 (USD MILLION)
TABLE 606 AUSTRALIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY POPULATION, 2022-2031 (USD MILLION)
TABLE 607 AUSTRALIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
TABLE 608 AUSTRALIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 609 AUSTRALIA HOSPITALS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 610 AUSTRALIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 611 AUSTRALIA RETAIL SALES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 612 SINGAPORE VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2031 (USD MILLION)
TABLE 613 SINGAPORE NON-STEROIDAL ANTI-INFLAMMATORY (NSAIDS) IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 614 SINGAPORE ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 615 SINGAPORE ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 616 SINGAPORE VACCINES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE , 2022-2031 (USD MILLION)
TABLE 617 SINGAPORE COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 618 SINGAPORE WHOLE VIRUS VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 619 SINGAPORE COMPONENT VIRAL VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 620 SINGAPORE COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY VARIANT , 2022-2031 (USD MILLION)
TABLE 621 SINGAPORE INFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 622 SINGAPORE MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 623 SINGAPORE MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 624 SINGAPORE VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 625 SINGAPORE VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 626 SINGAPORE ORAL IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 627 SINGAPORE INJECTABLES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 628 SINGAPORE VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 629 SINGAPORE PARAINFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 630 SINGAPORE ENTEROVIRUS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 631 SINGAPORE VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY INFECTION TYPE, 2022-2031 (USD MILLION)
TABLE 632 SINGAPORE VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY POPULATION, 2022-2031 (USD MILLION)
TABLE 633 SINGAPORE VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
TABLE 634 SINGAPORE VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 635 SINGAPORE HOSPITALS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 636 SINGAPORE VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 637 SINGAPORE RETAIL SALES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 638 THAILAND VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2031 (USD MILLION)
TABLE 639 THAILAND NON-STEROIDAL ANTI-INFLAMMATORY (NSAIDS) IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 640 THAILAND ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 641 THAILAND ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 642 THAILAND VACCINES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE , 2022-2031 (USD MILLION)
TABLE 643 THAILAND COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 644 THAILAND WHOLE VIRUS VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 645 THAILAND COMPONENT VIRAL VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 646 THAILAND COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY VARIANT , 2022-2031 (USD MILLION)
TABLE 647 THAILAND INFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 648 THAILAND MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 649 THAILAND MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 650 THAILAND VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 651 THAILAND VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 652 THAILAND ORAL IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 653 THAILAND INJECTABLES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 654 THAILAND VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 655 THAILAND PARAINFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 656 THAILAND ENTEROVIRUS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 657 THAILAND VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY INFECTION TYPE, 2022-2031 (USD MILLION)
TABLE 658 THAILAND VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY POPULATION, 2022-2031 (USD MILLION)
TABLE 659 THAILAND VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
TABLE 660 THAILAND VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 661 THAILAND HOSPITALS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 662 THAILAND VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 663 THAILAND RETAIL SALES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 664 MALAYSIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2031 (USD MILLION)
TABLE 665 MALAYSIA NON-STEROIDAL ANTI-INFLAMMATORY (NSAIDS) IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 666 MALAYSIA ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 667 MALAYSIA ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 668 MALAYSIA VACCINES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE , 2022-2031 (USD MILLION)
TABLE 669 MALAYSIA COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 670 MALAYSIA WHOLE VIRUS VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 671 MALAYSIA COMPONENT VIRAL VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 672 MALAYSIA COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY VARIANT , 2022-2031 (USD MILLION)
TABLE 673 MALAYSIA INFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 674 MALAYSIA MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 675 MALAYSIA MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 676 MALAYSIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 677 MALAYSIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 678 MALAYSIA ORAL IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 679 MALAYSIA INJECTABLES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 680 MALAYSIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 681 MALAYSIA PARAINFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 682 MALAYSIA ENTEROVIRUS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 683 MALAYSIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY INFECTION TYPE, 2022-2031 (USD MILLION)
TABLE 684 MALAYSIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY POPULATION, 2022-2031 (USD MILLION)
TABLE 685 MALAYSIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
TABLE 686 MALAYSIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 687 MALAYSIA HOSPITALS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 688 MALAYSIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 689 MALAYSIA RETAIL SALES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 690 INDONESIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2031 (USD MILLION)
TABLE 691 INDONESIA NON-STEROIDAL ANTI-INFLAMMATORY (NSAIDS) IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 692 INDONESIA ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 693 INDONESIA ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 694 INDONESIA VACCINES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE , 2022-2031 (USD MILLION)
TABLE 695 INDONESIA COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 696 INDONESIA WHOLE VIRUS VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 697 INDONESIA COMPONENT VIRAL VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 698 INDONESIA COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY VARIANT , 2022-2031 (USD MILLION)
TABLE 699 INDONESIA INFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 700 INDONESIA MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 701 INDONESIA MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 702 INDONESIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 703 INDONESIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 704 INDONESIA ORAL IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 705 INDONESIA INJECTABLES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 706 INDONESIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 707 INDONESIA PARAINFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 708 INDONESIA ENTEROVIRUS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 709 INDONESIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY INFECTION TYPE, 2022-2031 (USD MILLION)
TABLE 710 INDONESIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY POPULATION, 2022-2031 (USD MILLION)
TABLE 711 INDONESIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
TABLE 712 INDONESIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 713 INDONESIA HOSPITALS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 714 INDONESIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 715 INDONESIA RETAIL SALES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 716 PHILIPPINES VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2031 (USD MILLION)
TABLE 717 PHILIPPINES NON-STEROIDAL ANTI-INFLAMMATORY (NSAIDS) IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 718 PHILIPPINES ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 719 PHILIPPINES ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 720 PHILIPPINES VACCINES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE , 2022-2031 (USD MILLION)
TABLE 721 PHILIPPINES COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 722 PHILIPPINES WHOLE VIRUS VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 723 PHILIPPINES COMPONENT VIRAL VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 724 PHILIPPINES COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY VARIANT , 2022-2031 (USD MILLION)
TABLE 725 PHILIPPINES INFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 726 PHILIPPINES MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 727 PHILIPPINES MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 728 PHILIPPINES VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 729 PHILIPPINES VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 730 PHILIPPINES ORAL IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 731 PHILIPPINES INJECTABLES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 732 PHILIPPINES VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 733 PHILIPPINES PARAINFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 734 PHILIPPINES ENTEROVIRUS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 735 PHILIPPINES VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY INFECTION TYPE, 2022-2031 (USD MILLION)
TABLE 736 PHILIPPINES VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY POPULATION, 2022-2031 (USD MILLION)
TABLE 737 PHILIPPINES VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
TABLE 738 PHILIPPINES VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 739 PHILIPPINES HOSPITALS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 740 PHILIPPINES VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 741 PHILIPPINES RETAIL SALES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 742 REST OF ASIA-PACIFIC VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2031 (USD MILLION)
TABLE 743 SOUTH AMERICA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 744 SOUTH AMERICA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2031 (USD MILLION)
TABLE 745 SOUTH AMERICA NON-STEROIDAL ANTI-INFLAMMATORY (NSAIDS) IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 746 SOUTH AMERICA ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 747 SOUTH AMERICA ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 748 SOUTH AMERICA VACCINES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE , 2022-2031 (USD MILLION)
TABLE 749 SOUTH AMERICA COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 750 SOUTH AMERICA WHOLE VIRUS VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 751 SOUTH AMERICA COMPONENT VIRAL VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 752 SOUTH AMERICA COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY VARIANT , 2022-2031 (USD MILLION)
TABLE 753 SOUTH AMERICA INFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 754 SOUTH AMERICA MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 755 SOUTH AMERICA MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 756 SOUTH AMERICA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 757 SOUTH AMERICA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 758 SOUTH AMERICA ORAL IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 759 SOUTH AMERICA INJECTABLES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 760 SOUTH AMERICA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 761 SOUTH AMERICA PARAINFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 762 SOUTH AMERICA ENTEROVIRUS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 763 SOUTH AMERICA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY INFECTION TYPE, 2022-2031 (USD MILLION)
TABLE 764 SOUTH AMERICA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY POPULATION, 2022-2031 (USD MILLION)
TABLE 765 SOUTH AMERICA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
TABLE 766 SOUTH AMERICA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 767 SOUTH AMERICA HOSPITALS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 768 SOUTH AMERICA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 769 SOUTH AMERICA RETAIL SALES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 770 BRAZIL VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2031 (USD MILLION)
TABLE 771 BRAZIL NON-STEROIDAL ANTI-INFLAMMATORY (NSAIDS) IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 772 BRAZIL ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 773 BRAZIL ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 774 BRAZIL VACCINES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE , 2022-2031 (USD MILLION)
TABLE 775 BRAZIL COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 776 BRAZIL WHOLE VIRUS VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 777 BRAZIL COMPONENT VIRAL VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 778 BRAZIL COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY VARIANT , 2022-2031 (USD MILLION)
TABLE 779 BRAZIL INFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 780 BRAZIL MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 781 BRAZIL MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 782 BRAZIL VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 783 BRAZIL VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 784 BRAZIL ORAL IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 785 BRAZIL INJECTABLES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 786 BRAZIL VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 787 BRAZIL PARAINFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 788 BRAZIL ENTEROVIRUS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 789 BRAZIL VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY INFECTION TYPE, 2022-2031 (USD MILLION)
TABLE 790 BRAZIL VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY POPULATION, 2022-2031 (USD MILLION)
TABLE 791 BRAZIL VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
TABLE 792 BRAZIL VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 793 BRAZIL HOSPITALS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 794 BRAZIL VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 795 BRAZIL RETAIL SALES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 796 ARGENTINA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2031 (USD MILLION)
TABLE 797 ARGENTINA NON-STEROIDAL ANTI-INFLAMMATORY (NSAIDS) IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 798 ARGENTINA ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 799 ARGENTINA ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 800 ARGENTINA VACCINES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE , 2022-2031 (USD MILLION)
TABLE 801 ARGENTINA COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 802 ARGENTINA WHOLE VIRUS VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 803 ARGENTINA COMPONENT VIRAL VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 804 ARGENTINA COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY VARIANT , 2022-2031 (USD MILLION)
TABLE 805 ARGENTINA INFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 806 ARGENTINA MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 807 ARGENTINA MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 808 ARGENTINA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 809 ARGENTINA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 810 ARGENTINA ORAL IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 811 ARGENTINA INJECTABLES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 812 ARGENTINA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 813 ARGENTINA PARAINFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 814 ARGENTINA ENTEROVIRUS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 815 ARGENTINA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY INFECTION TYPE, 2022-2031 (USD MILLION)
TABLE 816 ARGENTINA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY POPULATION, 2022-2031 (USD MILLION)
TABLE 817 ARGENTINA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
TABLE 818 ARGENTINA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 819 ARGENTINA HOSPITALS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 820 ARGENTINA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 821 ARGENTINA RETAIL SALES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 822 REST OF SOUTH AMERICA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2031 (USD MILLION)
TABLE 823 MIDDLE EAST AND AFRICA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 824 MIDDLE EAST AND AFRICA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2031 (USD MILLION)
TABLE 825 MIDDLE EAST AND AFRICA NON-STEROIDAL ANTI-INFLAMMATORY (NSAIDS) IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 826 MIDDLE EAST AND AFRICA ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 827 MIDDLE EAST AND AFRICA ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 828 MIDDLE EAST AND AFRICA VACCINES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE , 2022-2031 (USD MILLION)
TABLE 829 MIDDLE EAST AND AFRICA COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 830 MIDDLE EAST AND AFRICA WHOLE VIRUS VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 831 MIDDLE EAST AND AFRICA COMPONENT VIRAL VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 832 MIDDLE EAST AND AFRICA COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY VARIANT , 2022-2031 (USD MILLION)
TABLE 833 MIDDLE EAST AND AFRICA INFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 834 MIDDLE EAST AND AFRICA MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 835 MIDDLE EAST AND AFRICA MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 836 MIDDLE EAST AND AFRICA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 837 MIDDLE EAST AND AFRICA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 838 MIDDLE EAST AND AFRICA ORAL IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 839 MIDDLE EAST AND AFRICA INJECTABLES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 840 MIDDLE EAST AND AFRICA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 841 MIDDLE EAST AND AFRICA PARAINFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 842 MIDDLE EAST AND AFRICA ENTEROVIRUS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 843 MIDDLE EAST AND AFRICA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY INFECTION TYPE, 2022-2031 (USD MILLION)
TABLE 844 MIDDLE EAST AND AFRICA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY POPULATION, 2022-2031 (USD MILLION)
TABLE 845 MIDDLE EAST AND AFRICA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
TABLE 846 MIDDLE EAST AND AFRICA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 847 MIDDLE EAST AND AFRICA HOSPITALS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 848 MIDDLE EAST AND AFRICA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 849 MIDDLE EAST AND AFRICA RETAIL SALES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 850 SOUTH AFRICA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2031 (USD MILLION)
TABLE 851 SOUTH AFRICA NON-STEROIDAL ANTI-INFLAMMATORY (NSAIDS) IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 852 SOUTH AFRICA ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 853 SOUTH AFRICA ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 854 SOUTH AFRICA VACCINES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE , 2022-2031 (USD MILLION)
TABLE 855 SOUTH AFRICA COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 856 SOUTH AFRICA WHOLE VIRUS VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 857 SOUTH AFRICA COMPONENT VIRAL VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 858 SOUTH AFRICA COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY VARIANT , 2022-2031 (USD MILLION)
TABLE 859 SOUTH AFRICA INFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 860 SOUTH AFRICA MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 861 SOUTH AFRICA MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 862 SOUTH AFRICA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 863 SOUTH AFRICA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 864 SOUTH AFRICA ORAL IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 865 SOUTH AFRICA INJECTABLES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 866 SOUTH AFRICA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 867 SOUTH AFRICA PARAINFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 868 SOUTH AFRICA ENTEROVIRUS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 869 SOUTH AFRICA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY INFECTION TYPE, 2022-2031 (USD MILLION)
TABLE 870 SOUTH AFRICA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY POPULATION, 2022-2031 (USD MILLION)
TABLE 871 SOUTH AFRICA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
TABLE 872 SOUTH AFRICA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 873 SOUTH AFRICA HOSPITALS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 874 SOUTH AFRICA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 875 SOUTH AFRICA RETAIL SALES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 876 SAUDI ARABIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2031 (USD MILLION)
TABLE 877 SAUDI ARABIA NON-STEROIDAL ANTI-INFLAMMATORY (NSAIDS) IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 878 SAUDI ARABIA ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 879 SAUDI ARABIA ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 880 SAUDI ARABIA VACCINES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE , 2022-2031 (USD MILLION)
TABLE 881 SAUDI ARABIA COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 882 SAUDI ARABIA WHOLE VIRUS VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 883 SAUDI ARABIA COMPONENT VIRAL VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 884 SAUDI ARABIA COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY VARIANT , 2022-2031 (USD MILLION)
TABLE 885 SAUDI ARABIA INFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 886 SAUDI ARABIA MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 887 SAUDI ARABIA MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 888 SAUDI ARABIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 889 SAUDI ARABIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 890 SAUDI ARABIA ORAL IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 891 SAUDI ARABIA INJECTABLES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 892 SAUDI ARABIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 893 SAUDI ARABIA PARAINFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 894 SAUDI ARABIA ENTEROVIRUS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 895 SAUDI ARABIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY INFECTION TYPE, 2022-2031 (USD MILLION)
TABLE 896 SAUDI ARABIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY POPULATION, 2022-2031 (USD MILLION)
TABLE 897 SAUDI ARABIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
TABLE 898 SAUDI ARABIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 899 SAUDI ARABIA HOSPITALS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 900 SAUDI ARABIA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 901 SAUDI ARABIA RETAIL SALES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 902 U.A.E. VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2031 (USD MILLION)
TABLE 903 U.A.E. NON-STEROIDAL ANTI-INFLAMMATORY (NSAIDS) IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 904 U.A.E. ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 905 U.A.E. ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 906 U.A.E. VACCINES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE , 2022-2031 (USD MILLION)
TABLE 907 U.A.E. COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 908 U.A.E. WHOLE VIRUS VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 909 U.A.E. COMPONENT VIRAL VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 910 U.A.E. COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY VARIANT , 2022-2031 (USD MILLION)
TABLE 911 U.A.E. INFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 912 U.A.E. MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 913 U.A.E. MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 914 U.A.E. VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 915 U.A.E. VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 916 U.A.E. ORAL IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 917 U.A.E. INJECTABLES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 918 U.A.E. VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 919 U.A.E. PARAINFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 920 U.A.E. ENTEROVIRUS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 921 U.A.E. VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY INFECTION TYPE, 2022-2031 (USD MILLION)
TABLE 922 U.A.E. VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY POPULATION, 2022-2031 (USD MILLION)
TABLE 923 U.A.E. VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
TABLE 924 U.A.E. VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 925 U.A.E. HOSPITALS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 926 U.A.E. VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 927 U.A.E. RETAIL SALES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 928 EGYPT VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2031 (USD MILLION)
TABLE 929 EGYPT NON-STEROIDAL ANTI-INFLAMMATORY (NSAIDS) IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 930 EGYPT ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 931 EGYPT ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 932 EGYPT VACCINES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE , 2022-2031 (USD MILLION)
TABLE 933 EGYPT COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 934 EGYPT WHOLE VIRUS VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 935 EGYPT COMPONENT VIRAL VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 936 EGYPT COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY VARIANT , 2022-2031 (USD MILLION)
TABLE 937 EGYPT INFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 938 EGYPT MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 939 EGYPT MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 940 EGYPT VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 941 EGYPT VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 942 EGYPT ORAL IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 943 EGYPT INJECTABLES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 944 EGYPT VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 945 EGYPT PARAINFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 946 EGYPT ENTEROVIRUS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 947 EGYPT VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY INFECTION TYPE, 2022-2031 (USD MILLION)
TABLE 948 EGYPT VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY POPULATION, 2022-2031 (USD MILLION)
TABLE 949 EGYPT VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
TABLE 950 EGYPT VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 951 EGYPT HOSPITALS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 952 EGYPT VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 953 EGYPT RETAIL SALES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 954 ISRAEL VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2031 (USD MILLION)
TABLE 955 ISRAEL NON-STEROIDAL ANTI-INFLAMMATORY (NSAIDS) IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 956 ISRAEL ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 957 ISRAEL ANTIVIRAL MEDICATIONS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 958 ISRAEL VACCINES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE , 2022-2031 (USD MILLION)
TABLE 959 ISRAEL COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 960 ISRAEL WHOLE VIRUS VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 961 ISRAEL COMPONENT VIRAL VACCINE IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 962 ISRAEL COVID IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY VARIANT , 2022-2031 (USD MILLION)
TABLE 963 ISRAEL INFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE , 2022-2031 (USD MILLION)
TABLE 964 ISRAEL MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 965 ISRAEL MONOCLONAL ANTIBDODIES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 966 ISRAEL VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 967 ISRAEL VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 968 ISRAEL ORAL IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 969 ISRAEL INJECTABLES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 970 ISRAEL VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 971 ISRAEL PARAINFLUENZA IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 972 ISRAEL ENTEROVIRUS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 973 ISRAEL VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY INFECTION TYPE, 2022-2031 (USD MILLION)
TABLE 974 ISRAEL VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY POPULATION, 2022-2031 (USD MILLION)
TABLE 975 ISRAEL VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
TABLE 976 ISRAEL VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 977 ISRAEL HOSPITALS IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 978 ISRAEL VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 979 ISRAEL RETAIL SALES IN VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 980 REST OF MIDDLE EAST AND AFRICA VIRAL RESPIRATORY INFECTIONS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2031 (USD MILLION)